Black Diamond Therapeutics Inc. – Underwriting Agreements Watch

from S-3 40 pages Black Diamond Therapeutics, Inc., a Delaware Corporation (The “Company”), Proposes, Subject to the Terms and Conditions Stated Herein, to Issue and Sell From Time to Time Through Jefferies LLC, as Sales Agent and/or Principal (The “Agent”), Shares of the Company’s Common Stock, Par Value $0.0001 Per Share (The “Common Shares”), Having an Aggregate Offering Price of Up to $150,000,000 on the Terms Set Forth in This Agreement (This “Agreement”). Section 1. Definitions (A) Certain Definitions. for Purposes of This Agreement, Capitalized Terms Used Herein and Not Otherwise Defined Shall Have the Following Respective Meanings

from 8-K 31 pages Black Diamond Therapeutics, Inc. 15,000,000 Shares of Common Stock Underwriting Agreement

from S-3ASR 40 pages Open Market Sale Agreementsm

from S-1/A 49 pages Black Diamond Therapeutics, Inc. [●] Shares of Common Stock Underwriting Agreement